- Tytuł:
-
[
Chinese expert consensus of antibody-drug conjugate toxicity management for breast cancer]. - Corporate Authors:
-
Breast Cancer Group, Branch of Oncologist,
Chinese Medical Doctor Association;
International Medical Exchange Society,Chinese Anti-Cancer Association - Źródło:
-
Zhonghua zhong liu za zhi [
Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2022 Sep 23; Vol. 44 (9), pp. 913-927. - Typ publikacji:
- Consensus Development Conference; Journal Article
- MeSH Terms:
-
Antineoplastic Agents, Immunological*/adverse effects
Antineoplastic Agents, Immunological*/therapeutic use
Breast Neoplasms*/therapy
Cytotoxins*/adverse effects
Cytotoxins*/therapeutic use
Immunoconjugates*/adverse effects
Immunoconjugates*/therapeutic use
Triple Negative Breast Neoplasms*/therapy
Ado-Trastuzumab Emtansine/adverse effects ; Ado-Trastuzumab Emtansine/therapeutic use ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/therapeutic use ; Camptothecin/adverse effects ; Consensus ; Female ; Humans ; Neutropenia/etiology ; Receptor, ErbB-2/metabolism ; Trastuzumab/adverse effects ; Trastuzumab/therapeutic use ;Ventricular Function ,Left
Czasopismo naukowe